298 related articles for article (PubMed ID: 27562847)
1. Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.
Wen J; Ariyannur PS; Ribeiro R; Tanaka M; Moffett JR; Kirmani BF; Namboodiri AM; Zhang Y
J Neuroimmune Pharmacol; 2016 Dec; 11(4):763-773. PubMed ID: 27562847
[TBL] [Abstract][Full Text] [Related]
2. Spasticity Treatment Ameliorates the Efficacy of Melatonin Therapy in Experimental Autoimmune Encephalomyelitis (EAE) Mouse Model of Multiple Sclerosis.
Ghareghani M; Zibara K; Sadeghi H; Farhadi N
Cell Mol Neurobiol; 2018 Jul; 38(5):1145-1151. PubMed ID: 29497878
[TBL] [Abstract][Full Text] [Related]
3. Arachidonyl trifluoromethyl ketone ameliorates experimental autoimmune encephalomyelitis via blocking peroxynitrite formation in mouse spinal cord white matter.
Vana AC; Li S; Ribeiro R; Tchantchou F; Zhang Y
Exp Neurol; 2011 Sep; 231(1):45-55. PubMed ID: 21683698
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Ribeiro R; Yu F; Wen J; Vana A; Zhang Y
Neuroscience; 2013 Dec; 254():427-42. PubMed ID: 24036373
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis.
Garay L; Gonzalez Deniselle MC; Meyer M; Costa JJ; Lima A; Roig P; De nicola AF
Brain Res; 2009 Aug; 1283():177-85. PubMed ID: 19497309
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.
Virgili N; Espinosa-Parrilla JF; Mancera P; Pastén-Zamorano A; Gimeno-Bayon J; Rodríguez MJ; Mahy N; Pugliese M
J Neuroinflammation; 2011 Nov; 8():149. PubMed ID: 22047130
[TBL] [Abstract][Full Text] [Related]
7. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
8. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
9. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
10. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).
Musgrave T; Benson C; Wong G; Browne I; Tenorio G; Rauw G; Baker GB; Kerr BJ
Brain Behav Immun; 2011 Nov; 25(8):1677-88. PubMed ID: 21723939
[TBL] [Abstract][Full Text] [Related]
11. Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis.
Chen SJ; Huang SH; Chen JW; Wang KC; Yang YR; Liu PF; Lin GJ; Sytwu HK
Int Immunopharmacol; 2016 Feb; 31():169-77. PubMed ID: 26735612
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of NADPH oxidase activation reduces EAE-induced white matter damage in mice.
Choi BY; Kim JH; Kho AR; Kim IY; Lee SH; Lee BE; Choi E; Sohn M; Stevenson M; Chung TN; Kauppinen TM; Suh SW
J Neuroinflammation; 2015 May; 12():104. PubMed ID: 26017142
[TBL] [Abstract][Full Text] [Related]
13. Effects of an aqueous extract of North American ginseng on MOG(35-55)-induced EAE in mice.
Bowie LE; Roscoe WA; Lui EM; Smith R; Karlik SJ
Can J Physiol Pharmacol; 2012 Jul; 90(7):933-9. PubMed ID: 22720838
[TBL] [Abstract][Full Text] [Related]
14. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
15. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models.
Neil S; Huh J; Baronas V; Li X; McFarland HF; Cherukuri M; Mitchell JB; Quandt JA
Brain Behav Immun; 2017 May; 62():332-343. PubMed ID: 28238951
[TBL] [Abstract][Full Text] [Related]
17. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
Wen J; Ribeiro R; Tanaka M; Zhang Y
Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
[TBL] [Abstract][Full Text] [Related]
18. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.
Eitan E; Hutchison ER; Greig NH; Tweedie D; Celik H; Ghosh S; Fishbein KW; Spencer RG; Sasaki CY; Ghosh P; Das S; Chigurapati S; Raymick J; Sarkar S; Chigurupati S; Seal S; Mattson MP
Exp Neurol; 2015 Nov; 273():151-60. PubMed ID: 26277686
[TBL] [Abstract][Full Text] [Related]
20. Xanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosis.
Honorat JA; Kinoshita M; Okuno T; Takata K; Koda T; Tada S; Shirakura T; Fujimura H; Mochizuki H; Sakoda S; Nakatsuji Y
PLoS One; 2013; 8(8):e71329. PubMed ID: 23951137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
